Apogee Home Health | |
5300 W Atlantic Ave Ste 303, Delray Beach, Florida 33484 | |
(561) 278-3272 | |
Name | Apogee Home Health |
---|---|
Location | 5300 W Atlantic Ave Ste 303, Delray Beach, Florida |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 109080 |
Ownership Type | Proprietary |
Service Area Zip Codes | 33401, 33403, 33405, 33411, 33415, 33417, 33426, 33428, 33432, 33433, 33434, 33435, 33436, 33437, 33444, 33445, 33446, 33458, 33460, 33461, 33462, 33463, 33467, 33472, 33480, 33483, 33484, 33486, 33487, 33496 |
NPI Number | 1316129752 |
Organization Name | APOGEE HEALTH CARE INC. |
Doing Business As | APOGEE HOME HEALTH |
Address | 15127 S Jog Rd Ste 202, Delray Beach, FL 33446 |
Phone Number | 561-278-3272 |
News Archive
ExonHit Therapeutics today announced the publication of Phase IIa results for EHT 0202, its lead candidate for the treatment of Alzheimer's disease, in the journal Current Alzheimer Research.
New research from the Centers for Disease Control and Prevention estimates that as many as 200,000 central line-associated bloodstream infections have been prevented among patients in intensive care units since 1990.
Cordis Neurovascular, Inc. has announced that the U.S. Food and Drug Administration has granted Humanitarian Device Exemption (HDE) approval for the CORDIS ENTERPRISE Vascular Reconstruction Device and Delivery System for use with embolic coils in the treatment of wide-neck intracranial aneurysms.
Prostate cancer, like many medical conditions, varies in presentation, treatment options, and outcomes. Undeniably, patients rely on the Internet for early education about their prostate cancer diagnosis or to fill information gaps from doctors. We use the Internet to research nearly every facet of our lives, and our physical wellbeing is no exception. But can we trust what we read? Better yet, can we understand it?
› Verified 9 days ago
Quality Rating: |
News Archive
ExonHit Therapeutics today announced the publication of Phase IIa results for EHT 0202, its lead candidate for the treatment of Alzheimer's disease, in the journal Current Alzheimer Research.
New research from the Centers for Disease Control and Prevention estimates that as many as 200,000 central line-associated bloodstream infections have been prevented among patients in intensive care units since 1990.
Cordis Neurovascular, Inc. has announced that the U.S. Food and Drug Administration has granted Humanitarian Device Exemption (HDE) approval for the CORDIS ENTERPRISE Vascular Reconstruction Device and Delivery System for use with embolic coils in the treatment of wide-neck intracranial aneurysms.
Prostate cancer, like many medical conditions, varies in presentation, treatment options, and outcomes. Undeniably, patients rely on the Internet for early education about their prostate cancer diagnosis or to fill information gaps from doctors. We use the Internet to research nearly every facet of our lives, and our physical wellbeing is no exception. But can we trust what we read? Better yet, can we understand it?
› Verified 9 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 100 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 100 | 98.6 |
How often the home health team checked patients’ risk of falling | 100 | 99.6 |
How often the home health team checked patients for depression | 100 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 89.3 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 88.1 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 100 | 96.4 |
News Archive
ExonHit Therapeutics today announced the publication of Phase IIa results for EHT 0202, its lead candidate for the treatment of Alzheimer's disease, in the journal Current Alzheimer Research.
New research from the Centers for Disease Control and Prevention estimates that as many as 200,000 central line-associated bloodstream infections have been prevented among patients in intensive care units since 1990.
Cordis Neurovascular, Inc. has announced that the U.S. Food and Drug Administration has granted Humanitarian Device Exemption (HDE) approval for the CORDIS ENTERPRISE Vascular Reconstruction Device and Delivery System for use with embolic coils in the treatment of wide-neck intracranial aneurysms.
Prostate cancer, like many medical conditions, varies in presentation, treatment options, and outcomes. Undeniably, patients rely on the Internet for early education about their prostate cancer diagnosis or to fill information gaps from doctors. We use the Internet to research nearly every facet of our lives, and our physical wellbeing is no exception. But can we trust what we read? Better yet, can we understand it?
› Verified 9 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 76.1 | 79.6 |
How often patients got better at getting in and out of bed | 83.5 | 81.1 |
How often patients got better at bathing | 78.2 | 82.3 |
How often patients’ breathing improved | 88.7 | 82.8 |
How often patients’ wounds improved or healed after an operation | - | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 72.4 | 75 |
How often home health patients had to be admitted to the hospital | 18.2 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 8.2 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 100 | 94 |
News Archive
ExonHit Therapeutics today announced the publication of Phase IIa results for EHT 0202, its lead candidate for the treatment of Alzheimer's disease, in the journal Current Alzheimer Research.
New research from the Centers for Disease Control and Prevention estimates that as many as 200,000 central line-associated bloodstream infections have been prevented among patients in intensive care units since 1990.
Cordis Neurovascular, Inc. has announced that the U.S. Food and Drug Administration has granted Humanitarian Device Exemption (HDE) approval for the CORDIS ENTERPRISE Vascular Reconstruction Device and Delivery System for use with embolic coils in the treatment of wide-neck intracranial aneurysms.
Prostate cancer, like many medical conditions, varies in presentation, treatment options, and outcomes. Undeniably, patients rely on the Internet for early education about their prostate cancer diagnosis or to fill information gaps from doctors. We use the Internet to research nearly every facet of our lives, and our physical wellbeing is no exception. But can we trust what we read? Better yet, can we understand it?
› Verified 9 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | Not Available |
Health team communicated well with them | Not Available |
Health team discussed medicines, pain, and home safety | Not Available |
How patients rated overall care from agency | Not Available |
News Archive
ExonHit Therapeutics today announced the publication of Phase IIa results for EHT 0202, its lead candidate for the treatment of Alzheimer's disease, in the journal Current Alzheimer Research.
New research from the Centers for Disease Control and Prevention estimates that as many as 200,000 central line-associated bloodstream infections have been prevented among patients in intensive care units since 1990.
Cordis Neurovascular, Inc. has announced that the U.S. Food and Drug Administration has granted Humanitarian Device Exemption (HDE) approval for the CORDIS ENTERPRISE Vascular Reconstruction Device and Delivery System for use with embolic coils in the treatment of wide-neck intracranial aneurysms.
Prostate cancer, like many medical conditions, varies in presentation, treatment options, and outcomes. Undeniably, patients rely on the Internet for early education about their prostate cancer diagnosis or to fill information gaps from doctors. We use the Internet to research nearly every facet of our lives, and our physical wellbeing is no exception. But can we trust what we read? Better yet, can we understand it?
› Verified 9 days ago
The patient survey data of Apogee Home Health is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 93 | 88 |
Percent of patients who reported that their home health team communicated well with them | 96 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 81 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 92 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 98 | 78 |
News Archive
ExonHit Therapeutics today announced the publication of Phase IIa results for EHT 0202, its lead candidate for the treatment of Alzheimer's disease, in the journal Current Alzheimer Research.
New research from the Centers for Disease Control and Prevention estimates that as many as 200,000 central line-associated bloodstream infections have been prevented among patients in intensive care units since 1990.
Cordis Neurovascular, Inc. has announced that the U.S. Food and Drug Administration has granted Humanitarian Device Exemption (HDE) approval for the CORDIS ENTERPRISE Vascular Reconstruction Device and Delivery System for use with embolic coils in the treatment of wide-neck intracranial aneurysms.
Prostate cancer, like many medical conditions, varies in presentation, treatment options, and outcomes. Undeniably, patients rely on the Internet for early education about their prostate cancer diagnosis or to fill information gaps from doctors. We use the Internet to research nearly every facet of our lives, and our physical wellbeing is no exception. But can we trust what we read? Better yet, can we understand it?
› Verified 9 days ago
Real Solutions Home Health Care Inc Location: 500 Gulfstream Blvd Ste 103a, Delray Beach, Florida 33483 Ratings: Phone: (561) 819-1999 | |
Empathy Care Inc Location: 4731 W Atlantic Ave Ste 7, Delray Beach, Florida 33445 Ratings: Phone: (561) 395-9101 | |
Usa Home Health Services, Inc. Location: 5300 W Atlantic Ave Ste 300, Delray Beach, Florida 33484 Ratings: Phone: (561) 482-6646 | |
Firstlantic Nursing Services, Inc. Location: 2605 W Atlantic Ave Bldg A Ste 202, Delray Beach, Florida 33445 Ratings: Phone: (561) 243-7979 | |
Preferred Nursing Services Inc Location: 15300 Jog Road Ste 203, Delray Beach, Florida 33446 Ratings: Phone: (561) 638-8385 | |
Southeast Homecare Location: 1200 Nw 17th Ave Ste 10 & 11, Delray Beach, Florida 33445 Ratings: NA Phone: (561) 962-4134 |